We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

50 hedge funds and large institutions have $550M invested in Dyne Therapeutics in 2020 Q3 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60.52% more ownership

Funds ownership: 0% → 60.52% (+61%)

Holders
50
Holders Change
+50
Holders Change %
–
% of All Funds
1.01%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.06%
New
50
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MAM
MPM Asset Management
Massachusetts
+$109M
2
Citadel Advisors
Citadel Advisors
Florida
+$65.1M
3
RCM
RA Capital Management
Massachusetts
+$61.6M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$55.8M
5
Franklin Resources
Franklin Resources
California
+$38.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
MPM Asset Management
Massachusetts
$100M +$109M +4,951,303 New
Citadel Advisors
2
Citadel Advisors
Florida
$59.9M +$65.1M +2,968,393 New
VVA
3
Vida Ventures Advisors
Massachusetts
$59.8M +$65M +2,960,046 New
RCM
4
RA Capital Management
Massachusetts
$56.6M +$61.6M +2,805,045 New
Wellington Management Group
5
Wellington Management Group
Massachusetts
$49.9M +$55.8M +2,542,760 New
Franklin Resources
6
Franklin Resources
California
$35.3M +$38.4M +1,747,557 New
LGM
7
Logos Global Management
California
$32.4M +$35.2M +1,604,392 New
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$19.9M +$21.6M +985,963 New
HA
9
HHLR Advisors
Cayman Islands
$12.1M +$13.2M +600,000 New
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$9.92M +$10.8M +491,471 New
Norges Bank
11
Norges Bank
Norway
$9.71M +$10.6M +480,769 New
SAM
12
Sectoral Asset Management
Quebec, Canada
$9.58M +$10.4M +474,301 New
DM
13
Deerfield Management
New York
$8.3M +$9.03M +411,267 New
PA
14
Perceptive Advisors
New York
$8.08M +$8.78M +400,000 New
AG
15
Artal Group
Luxembourg
$7.47M +$8.12M +370,000 New
CC
16
Casdin Capital
New York
$7.47M +$8.12M +370,000 New
O
17
OrbiMed
New York
$7.07M +$7.68M +350,000 New
VC
18
Vivo Capital
California
$6.36M +$6.91M +315,000 New
BlackRock
19
BlackRock
New York
$6.14M +$6.67M +304,000 New
WP
20
Woodline Partners
California
$5.39M +$5.85M +266,799 New
EC
21
EcoR1 Capital
California
$4.34M +$4.72M +215,000 New
ACH
22
ArrowMark Colorado Holdings
Colorado
$4.04M +$4.39M +200,000 New
FCM
23
Farallon Capital Management
California
$4.04M +$4.39M +200,000 New
Goldman Sachs
24
Goldman Sachs
New York
$3.59M +$3.91M +177,987 New
HM
25
HealthCor Management
New York
$2.42M +$2.63M +120,000 New
1
2

DYN Hedge Fund Activity: Q3 2020 in Review

50 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q3 2020, worth a combined $550M.

Buyers outnumbered sellers: 50 funds opened new DYN positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was MPM Asset Management, opening a new position worth an estimated $109M.

  • 50 institutional investors held Dyne Therapeutics (DYN) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $550M of Dyne Therapeutics stock for Q3 2020.
  • 50 funds opened new Dyne Therapeutics positions in Q3 2020 and 0 closed out, a net change of +50 holders.
  • The largest Dyne Therapeutics buyer in Q3 2020 was MPM Asset Management, an estimated $109M added.

Based on aggregated 13F filings for Q3 2020.